Bosentan therapy for pulmonary arterial hypertension.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Bosentan therapy for pulmonary arterial hypertension.
- Published In:
- The New England journal of medicine, 346(12), 896-903 (2002)
- Authors:
- Rubin, Lewis J, Badesch, David B, Barst, Robyn J, Galie, Nazzareno, Black, Carol M, Keogh, Anne, Pulido, Tomas, Frost, Adaani, Roux, Sebastien, Leconte, Isabelle, Landzberg, Michael, Simonneau, Gerald
- Database ID:
- RPEP-00764
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-00764APA
Rubin, Lewis J; Badesch, David B; Barst, Robyn J; Galie, Nazzareno; Black, Carol M; Keogh, Anne; Pulido, Tomas; Frost, Adaani; Roux, Sebastien; Leconte, Isabelle; Landzberg, Michael; Simonneau, Gerald. (2002). Bosentan therapy for pulmonary arterial hypertension.. The New England journal of medicine, 346(12), 896-903.
MLA
Rubin, Lewis J, et al. "Bosentan therapy for pulmonary arterial hypertension.." The New England journal of medicine, 2002.
RethinkPeptides
RethinkPeptides Research Database. "Bosentan therapy for pulmonary arterial hypertension." RPEP-00764. Retrieved from https://rethinkpeptides.com/research/rubin-2002-bosentan-therapy-for-pulmonary
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.